| Literature DB >> 17214898 |
Eric Yang1, Timothy Maguire, Martin L Yarmush, Francois Berthiaume, Ioannis P Androulakis.
Abstract
BACKGROUND: Thermal injury is among the most severe forms of trauma and its effects are both local and systemic. Response to thermal injury includes cellular protection mechanisms, inflammation, hypermetabolism, prolonged catabolism, organ dysfunction and immuno-suppression. It has been hypothesized that gene expression patterns in the liver will change with severe burns, thus reflecting the role the liver plays in the response to burn injury. Characterizing the molecular fingerprint (i.e., expression profile) of the inflammatory response resulting from burns may help elucidate the activated mechanisms and suggest new therapeutic intervention. In this paper we propose a novel integrated framework for analyzing time-series transcriptional data, with emphasis on the burn-induced response within the context of the rat animal model. Our analysis robustly identifies critical expression motifs, indicative of the dynamic evolution of the inflammatory response and we further propose a putative reconstruction of the associated transcription factor activities.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17214898 PMCID: PMC1797813 DOI: 10.1186/1471-2105-8-10
Source DB: PubMed Journal: BMC Bioinformatics ISSN: 1471-2105 Impact factor: 3.169
Gene Ontology Enrichment of Informative motifs
| protein biosynthesis | 0.082 | 0.568 | 1.000 | |
| ribosome biogenesis | 0.314 | 1.000 | 1.000 | |
| response to unfolded protein | 0.268 | 1.000 | 1.000 | |
| protein folding | 0.178 | 1.000 | 1.000 | |
| peptidyl-arginine methylation, to asymmetrical-dimethyl arginine | 1.000 | 1.000 | 1.000 | |
| protein-nucleus export | 1.000 | 1.000 | 1.000 | |
| adenine metabolism | 1.000 | 1.000 | 1.000 | |
| response to stress | 1.000 | 1.000 | 1.000 | |
| pyridoxine biosynthesis | 1.000 | 1.000 | 1.000 | |
| endothelial cell differentiation | 1.000 | 1.000 | 1.000 | |
| hormone-mediated signaling | 1.000 | 1.000 | 1.000 | |
| re-entry into mitotic cell cycle | 1.000 | 1.000 | 1.000 | |
| protein amino acid prenylation | 1.000 | 1.000 | 1.000 | |
| transmission of nerve impulse | 1.000 | 1.000 | 1.000 | |
| negative regulation of calcium-mediated signaling | 1.000 | 1.000 | 1.000 | |
| Acute phase response genes | 1.000 | 1.000 | 1.000 | |
| ubiquitin-dependent protein catabolism | 0.288 | 0.284 | 1.000 | |
| ureteric bud development | 1.000 | 1.000 | 1.000 | |
| nucleosome assembly | 1.000 | 0.128 | 1.000 | |
| protein catabolism | 1.000 | 1.000 | 1.000 | |
| homophilic cell adhesion | 0.149 | 1.000 | 0.143 | |
| norepinephrine biosynthesis | 1.000 | 1.000 | 1.000 | |
| protein refolding | 1.000 | 1.000 | 1.000 | |
| chaperone cofactor dependent protein folding | 1.000 | 1.000 | 1.000 | |
| N-acetylglucosamine metabolism | 1.000 | 1.000 | 1.000 | |
| thyroid hormone catabolism | 1.000 | 1.000 | 1.000 | |
| cellular response to starvation | 1.000 | 1.000 | 1.000 | |
| negative regulation of Ras protein signal transduction | 1.000 | 1.000 | 1.000 | |
| RNA processing | 1.000 | 1.000 | 1.000 | |
| cell glucose homeostasis | 1.000 | 1.000 | 1.000 | |
| protein amino acid dephosphorylation | 0.436 | 0.494 | 0.421 | |
| cytokinesis | 1.000 | 1.000 | 1.000 | |
| nucleocytoplasmic transport | 1.000 | 1.000 | 1.000 | |
| negative regulation of transcription, DNA-dependent | 0.116 | 1.000 | 1.000 | |
| somitogenesis | 1.000 | 1.000 | 1.000 | |
| glycogen metabolism | 1.000 | 1.000 | 1.000 | |
| thioredoxin pathway | 1.000 | 1.000 | 1.000 | |
| negative regulation of Wnt receptor signaling pathway | 1.000 | 1.000 | ||
| negative regulation of neuron differentiation | 1.000 | 1.000 | 1.000 | |
| frizzled signaling pathway | 1.000 | 1.000 | 1.000 | |
| tRNA processing | 1.000 | 1.000 | 1.000 | |
| regulation of Wnt receptor signaling pathway | 1.000 | 1.000 | 1.000 | |
| interleukin-2 biosynthesis | 1.000 | 1.000 | 1.000 | |
| RNA-nucleus export | 1.000 | 1.000 | 1.000 | |
| Golgi organization and biogenesis | 1.000 | 1.000 | 1.000 | |
| regulation of transcription, DNA-dependent | 0.077 | 0.166 | 1.000 | |
| grooming behavior | 1.000 | 1.000 | 1.000 | |
| medium-chain fatty acid transport | 1.000 | 1.000 | 1.000 | |
| embryonic placenta development | 1.000 | 1.000 | 1.000 | |
| catecholamine catabolism | 1.000 | 1.000 | 1.000 | |
| inflammatory response | 0.494 | 1.000 | 1.000 | |
| inflammatory response | 0.494 | 1.000 | 1.000 | |
| embryo implantation | 1.000 | 1.000 | 1.000 | |
| synaptic vesicle endocytosis | 1.000 | 1.000 | 1.000 | |
| response to acid | 1.000 | 1.000 | 1.000 | |
| associative learning | 1.000 | 1.000 | 1.000 | |
| nitrogen fixation | 1.000 | 1.000 | 1.000 | |
| regulation of dopamine metabolism | 1.000 | 1.000 | 1.000 | |
| mesoderm cell differentiation | 1.000 | 1.000 | 1.000 | |
| regulation of transcription | 1.000 | 1.000 | 1.000 | |
| vasculogenesis | 1.000 | 1.000 | 1.000 | |
| fatty acid transport | 1.000 | 1.000 | 1.000 | |
Transcription factor enrichment of informative motifs
| AHR-arnt heterodimers and AHR-related factors | 0.37 | 0.45 | 0.36 | |
| E-box binding factor without transcript. activation | 0.74 | 0.78 | 0.78 | |
| Brn POU domain factors | 0.19 | 0.19 | 0.23 | |
| CAS interating zinc finger protein | 0.22 | 0.28 | 0.15 | |
| MYOblast Determining factor | 0.13 | 0.23 | 0.16 | |
| GC-Box factors_SP1/GC | 0.15 | 0.24 | 0.12 | |
| Cell cycle regulators: Cell cycle dependent element | 0.64 | 0.69 | 0.70 | |
| Promoter CCAAT binding factors | 0.20 | 0.16 | 0.31 | |
| RBPJ – kappa | 0.27 | 0.28 | 0.17 | |
| C-myb, cellular transcriptional activator | 0.28 | 0.28 | 0.15 | |
| CP2-erythrocyte Factor related to drosophila Elf1 | 0.24 | 0.26 | 0.36 | |
| Homeodomain factor aberrantly expressed in myeloid leukemia | 0.23 | 0.23 | 0.23 | |
| OCT1 binding factor (POU-specific domain) | 0.25 | 0.25 | 0.14 | |
| AP4 and Related proteins | 0.11 | 0.18 | 0.23 | |
| MAF and AP1 related factors | 0.27 | 0.27 | 0.23 | |
| NKX/DLX – homeodomain sites | 0.96 | 0.74 | 0.20 | |
| Interferon Regulatory Factors | 0.18 | 0.91 | 0.18 | |
| CLOX and CLOX homology (CDP) factors | 0.25 | 0.73 | 0.52 | |
| p53 tumor suppr.-neg. regulat. of the tumor suppr. Rb | 0.12 | 0.21 | 0.28 | |
| Basic and erythroid Krueppel like factors | 0.17 | 0.24 | 0.17 | |
| Pancreatic and intestinal homeodomain transcr. factor | 0.23 | 0.20 | 0.24 | |
| Microphthalmia transcription factor | 0.37 | 0.24 | 0.37 | |
| Human and murine ETS1 factors | 0.95 | 0.86 | 0.36 | |
| Regulator of B-Cell IgH transcription | 0.28 | 0.22 | 0.28 | |
| Hypoxia inducible factor, bHLH/PAS protein family | 0.37 | 0.36 | 0.43 | |
| E-box related factors | 0.37 | 0.36 | 0.37 | |
| ZF5 POZ domain zinc finger | 0.31 | 0.11 | 0.60 | |
| PAX-2 binding sites | 0.37 | 0.24 | 0.22 | |
| CCAAT/Enhancer Binding Protein | 0.16 | 0.19 | 0.23 | |
| E2F-myc activator/cell cycle regulator | 0.27 | 0.20 | ||
| Vertebrate caudal related homeodomain protein | 0.23 | 0.23 | ||
| FAST-1 SMAD interacting proteins | 0.13 | 0.12 | ||
| AMV-viral myb oncogene | 0.11 | 0.20 | ||
| Camp-Responsive Element Binding proteins | 0.17 | 0.12 | ||
| Octamer binding protein | 1.00 | 0.96 | ||
| AARE binding factors | 0.31 | 0.37 | ||
| Nuclear Factor Kappa B/c-rel | 0.22 | 0.22 | ||
| Zinc binding protein factor | 0.20 | 0.21 | ||
| Hepatic Nuclear Factor 1 | 0.15 | 0.23 | ||
Figure 1Motif Distribution(top) and expression profile of the selected genes(bottom). Cluster 1–4 have been selected by the algorithm as being informative.
Figure 2The evolution of the transcriptional state vs. time. (Top) The transcriptional state of an informative set of genes. (Bottom) The transcriptional state of the entire array.
Figure 3KS-metric evolution vs. number of peaks added (top). KS-metric temporal evolution of informative vs. uninformative genes (bottom).
Figure 4Relative probability of a particular transcription factor binding to any given cluster. The transcription factor index is an ID number specifying each transcription factor numbered 1-N, where N is the number of transcription factors in our analysis. The brighter the color, the more statistically significant the transcription factor enrichment.
Figure 5Typical profiles of Transcription Factor Activity Obtained from NCA. The transcription factors in bold are hypothesized as being more important based upon the scale of their activity. The cutoff was calculated by taking the transcription factor that showed the greatest difference over the experimental time period. Other transcription factors were included if their maximum difference was within the bootstrapped confidence intervals [85] of the originally selected profile.
Figure 6Gene interaction network formed by the informative genes associated with the burn-induced inflammatory response. For better visual inspection the highly interconnected hubs has been isolated and clearly indicated.
Comparative Assessment with Other Clustering Methods
| % enriched GO | 0.11 | 0.13 | 0.35 | 0.30 |
| % inflammation-specific enriched GO | 0.40 | 0.40 | 0.50 | |
| % enriched TFs | 0.08 | 0.13 | 0.28 | 0.17 |
| % inflammation-specific enriched TFs | 0.25 | 0.28 | 0.28 |
Figure 7An example of a HOT-SAX transformation of a time series (w = 2, α = 3).